Characteristics of Children Aged 0 to 23 Months Hospitalized With Respiratory Syncytial Virus
{{output}}
Background and objectives: Respiratory syncytial virus (RSV) is a leading cause of hospitalization among young children. Nirsevimab is recommended for all infants younger than 8 months and children aged 8 to 19 months who are at ... ...
